|
Aug 16
|
ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023)
|
|
Aug 13
|
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
|
|
May 8
|
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024
|
|
Apr 9
|
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
|
|
Aug 7
|
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
|